Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002133 · ClinicalTrials.gov registry record · NA
An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
A NA study, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
NCT00002133: Completed NA study, sponsored by Janssen.
NCT00002133 is a NA study that has completed, run by Janssen. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002133, a NA study, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.
Interventions
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002133 record still lists
NCT00002133 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Itraconazole is the first listed.
NCT00002133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002133 about?
NCT00002133 is a clinical study titled "An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.". To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.
What is the current status of trial NCT00002133?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002133?
The interventions under investigation include: Itraconazole (DRUG).
Who is sponsoring clinical trial NCT00002133?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.